AIM ImmunoTech Inc. — Director's Dealing 2020

Dec 11, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AIM ImmunoTech Inc. (AIM)
CIK: 0000946644
Period of Report: 2020-12-09

Reporting Person: LINTAL ELLEN M (Chief Financial Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-12-09	Options	$1.85	A	75000	Acquired	2030-12-09	Common Stock (75000)	Direct